Literature DB >> 29278831

Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.

Peter J Davidson1, Andrea M Lopez2, Alex H Kral3.   

Abstract

BACKGROUND: Supervised injection facilities (SIFs) are spaces where people can consume pre-obtained drugs in hygienic circumstances with trained staff in attendance to provide emergency response in the event of an overdose or other medical emergency, and to provide counselling and referral to other social and health services. Over 100 facilities with formal legal sanction exist in ten countries, and extensive research has shown they reduce overdose deaths, increase drug treatment uptake, and reduce social nuisance. No facility with formal legal sanction currently exists in the United States, however one community-based organization has successfully operated an 'underground' facility since September 2014.
METHODS: Twenty three qualitative interviews were conducted with people who used the underground facility, staff, and volunteers to examine the impact of the facility on peoples' lives, including the impact of lack of formal legal sanction on service provision.
RESULTS: Participants reported that having a safe space to inject drugs had led to less injections in public spaces, greater ability to practice hygienic injecting practices, and greater protection from fatal overdose. Constructive aspects of being 'underground' included the ability to shape rules and procedures around user need rather than to meet political concerns, and the rapid deployment of the project, based on immediate need. Limitations associated with being underground included restrictions in the size and diversity of the population served by the site, and reduced ability to closely link the service to drug treatment and other health and social services.
CONCLUSION: Unsanctioned supervised injection facilities can provide a rapid and user-driven response to urgent public health needs. This work draws attention to the need to ensure such services remain focused on user-defined need rather than external political concerns in jurisdictions where supervised injection facilities acquire local legal sanction.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Harm reduction; Law; Overdose; People who inject drugs; Supervised injection facilities

Mesh:

Substances:

Year:  2017        PMID: 29278831     DOI: 10.1016/j.drugpo.2017.12.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  14 in total

1.  Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.

Authors:  Alexis M Roth; Alex H Kral; Allison Mitchell; Rohit Mukherjee; Peter Davidson; Stephen E Lankenau
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

2.  Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis.

Authors:  Grace H Yoon; Timothy W Levengood; Melissa J Davoust; Shannon N Ogden; Alex H Kral; Sean R Cahill; Angela R Bazzi
Journal:  Harm Reduct J       Date:  2022-07-05

3.  Peer-to-peer injection: Demographic, drug use, and injection-related risk factors.

Authors:  Shona Lamb; Alex H Kral; Karina Dominguez-Gonzalez; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Int J Drug Policy       Date:  2018-10-31

4.  "And we just have to keep going": Task shifting and the production of burnout among overdose response workers with lived experience.

Authors:  Michelle Olding; Jade Boyd; Thomas Kerr; Ryan McNeil
Journal:  Soc Sci Med       Date:  2021-01-05       Impact factor: 4.634

5.  Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19.

Authors:  Michelle Olding; Allison Barker; Ryan McNeil; Jade Boyd
Journal:  Int J Drug Policy       Date:  2020-12-10

6.  Assisted injection provider practices and motivations in Los Angeles and San Francisco California 2016-18.

Authors:  Sarah Brothers; Alex H Kral; Lynn Wenger; Kelsey Simpson; Ricky N Bluthenthal
Journal:  Int J Drug Policy       Date:  2020-11-28

7.  Characterizing stimulant overdose: A qualitative study on perceptions and experiences of "overamping".

Authors:  Manal Mansoor; Ryan McNeil; Taylor Fleming; Allison Barker; Sheila Vakharia; Kimberly Sue; Andrew Ivsins
Journal:  Int J Drug Policy       Date:  2022-01-31

8.  Activism and scientific research: 20 years of community action by the Vancouver area network of drug users.

Authors:  Ehsan Jozaghi; Alissa M Greer; Hugh Lampkin; Jane A Buxton
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-05-22

9.  Practices of care among people who buy, use, and sell drugs in community settings.

Authors:  Gillian Kolla; Carol Strike
Journal:  Harm Reduct J       Date:  2020-05-07

Review 10.  Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.

Authors:  Taylor Fleming; Allison Barker; Andrew Ivsins; Sheila Vakharia; Ryan McNeil
Journal:  Harm Reduct J       Date:  2020-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.